Home Data Calendar Blog

INBX

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Common Stock Value 0.010.000.000.000.000.000.000.000.000.000.000.000.00NANA0.00NA
Weighted Average Number Of Diluted Shares Outstanding 47.1543.6443.58NA39.0739.0439.02NA37.8937.8237.74NA26.7510.44NANANA
Weighted Average Number Of Shares Outstanding Basic 47.1543.6443.58NA39.0739.0439.02NA37.8937.8237.74NA26.7510.44NANANA
Earnings Per Share Basic -1.10-1.08-1.12-0.95-0.90-0.97-0.80-0.55-0.54-0.55-0.51-0.23-0.77-1.72NANANA
Earnings Per Share Diluted -1.10-1.08-1.12-0.95-0.90-0.97-0.80-0.55-0.54-0.55-0.51-0.23-0.77-1.72NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Revenues 0.120.030.020.270.280.710.932.862.530.950.892.785.903.340.870.261.22
Operating Expenses 45.9541.3743.7835.7730.2835.3129.9522.2621.3320.7519.4519.8821.4620.5118.4816.7214.27
Research And Development Expense 38.0634.1137.3930.4524.9329.9124.8918.6118.4817.9016.4417.6719.8418.9717.0212.2812.79
General And Administrative Expense 7.897.266.405.325.355.405.053.652.852.853.012.211.621.531.471.671.48
Operating Income Loss -45.83-41.34-43.77-35.50-30.00-34.60-29.02-19.40-18.80-19.80-18.56-17.11-15.56-17.17-17.61-16.45-13.05
Interest Paid Net NA6.676.285.263.862.471.501.890.680.720.600.330.130.000.040.07NA
Interest Income Expense Nonoperating Net NANA-5.08-5.34-5.34-3.15-2.27-1.78-1.78-0.91-0.74-0.53-4.43-3.40-2.45-2.31-2.67
Income Tax Expense Benefit 0.000.01NA-0.000.000.00NA0.000.000.000.00NANANANA0.000.90
Net Income Loss -51.79-47.05-48.92-40.91-35.33-37.73-31.25-21.19-20.58-20.71-19.29-17.65-20.50-17.89-20.09-16.30-20.16

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Assets 372.73213.17253.72290.88164.85193.21161.18150.45129.18141.89124.50143.74143.55NANA26.49NA
Liabilities 243.14237.98238.58232.82199.90198.13133.8398.07100.9897.5763.9168.2751.83NANA60.55NA
Liabilities And Stockholders Equity 372.73213.17253.72290.88164.85193.21161.18150.45129.18141.89124.50143.74143.55NANA26.49NA
Stockholders Equity 129.59-24.8115.1358.06-35.05-4.9227.3552.3828.2044.3260.5975.4791.73NANA-93.57NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Assets Current 363.30203.32243.78280.49153.75181.62150.40139.11119.03131.28113.40132.17131.85NANA15.56NA
Cash And Cash Equivalents At Carrying Value 337.33192.49234.25273.87146.07176.38143.47131.30112.70125.73107.99128.66127.67NANA11.54NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 337.33192.49234.25273.87146.07176.38143.47131.30112.70125.73107.99128.66127.675.630.4311.5424.26
Accounts Receivable Net Current NANA0.300.240.240.240.380.370.120.220.040.080.68NANA0.20NA
Other Assets Current 0.340.320.210.670.830.610.600.590.750.620.680.690.97NANA0.38NA
Prepaid Expense And Other Assets Current 25.6410.509.226.377.374.956.506.935.835.025.052.893.22NANA3.58NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Property Plant And Equipment Gross 9.258.938.308.048.067.897.717.567.287.077.046.866.37NANA5.61NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 6.396.105.815.545.265.024.724.414.103.803.663.373.10NANA2.38NA
Property Plant And Equipment Net 2.862.832.482.502.802.882.993.153.183.263.393.493.27NANA3.23NA
Other Assets Noncurrent 3.163.163.163.163.163.161.851.850.240.240.240.240.24NANA0.24NA
Available For Sale Debt Securities Amortized Cost Basis NA133.70198.40196.30NANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Liabilities Current 35.7731.3332.6427.5825.4324.2020.1122.4525.1521.6727.8531.4034.74NANA20.57NA
Accounts Payable Current 7.869.7010.928.338.579.257.899.1212.439.8614.2913.4615.19NANA3.12NA
Other Accrued Liabilities Current 0.340.340.460.231.821.010.900.650.600.400.410.380.17NANA0.29NA
Accrued Liabilities Current 25.9019.5519.6717.2214.6112.479.279.628.336.987.9413.3611.04NANA4.83NA
Contract With Customer Liability Current NA0.120.150.170.440.721.232.032.773.244.083.085.18NANA7.94NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Secured Long Term Debt 205.72204.48203.26202.07170.82169.80109.1470.4770.0769.6729.4529.249.82NANANANA
Operating Lease Liability Noncurrent 1.652.172.683.173.664.134.595.035.475.906.316.717.10NANA6.70NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Stockholders Equity 129.59-24.8115.1358.06-35.05-4.9227.3552.3828.2044.3260.5975.4791.73NANA-93.57NA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest NANANANA-35.05-4.9227.3552.3828.2044.3260.5975.4791.73-126.54-112.57-93.57-78.39
Common Stock Value 0.010.000.000.000.000.000.000.000.000.000.000.000.00NANA0.00NA
Additional Paid In Capital 649.72443.52436.42430.43296.40291.21285.75279.53234.15229.69225.26220.85219.46NANA-24.32NA
Retained Earnings Accumulated Deficit -520.13-468.34-421.29-372.37-331.46-296.13-258.40-227.15-205.96-185.38-164.67-145.38-127.73NANA-69.25NA
Stock Issued During Period Value New Issues 199.65NANANANANANANANANANANA125.86NANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 6.536.255.64NA4.695.305.11NA3.493.953.42NA1.301.261.09NA1.02

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Net Cash Provided By Used In Operating Activities -54.24-42.30-39.94-30.60-30.84-26.92-26.94-22.62-13.68-22.38-21.65-15.39-13.88-11.31-7.39-11.94NA
Net Cash Provided By Used In Investing Activities -0.81-0.32-0.02-0.270.02-0.32-0.12-0.27-0.17-0.36-0.01-0.61-0.30-0.36-0.09-0.34NA
Net Cash Provided By Used In Financing Activities 199.890.850.36158.660.5160.1639.2241.480.8240.480.9917.00136.2216.88-3.63-0.44NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Net Cash Provided By Used In Operating Activities -54.24-42.30-39.94-30.60-30.84-26.92-26.94-22.62-13.68-22.38-21.65-15.39-13.88-11.31-7.39-11.94NA
Net Income Loss -51.79-47.05-48.92-40.91-35.33-37.73-31.25-21.19-20.58-20.71-19.29-17.65-20.50-17.89-20.09-16.30-20.16
Depreciation Depletion And Amortization 0.300.300.290.300.300.300.310.310.300.300.290.270.300.200.260.240.50
Increase Decrease In Accounts Receivable 0.000.020.060.000.00-0.130.000.13-0.100.18-0.05-0.600.680.01-0.20-2.17NA
Increase Decrease In Accounts Payable -1.59-1.542.330.02-0.941.47-1.26-3.412.34-4.230.66-1.185.93-0.636.30-0.46NA
Share Based Compensation 6.536.255.645.364.695.305.114.183.493.953.421.371.301.261.091.12NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Net Cash Provided By Used In Investing Activities -0.81-0.32-0.02-0.270.02-0.32-0.12-0.27-0.17-0.36-0.01-0.61-0.30-0.36-0.09-0.34NA
Payments To Acquire Property Plant And Equipment 0.810.320.020.27-0.020.320.120.270.170.410.010.610.300.360.090.34NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Net Cash Provided By Used In Financing Activities 199.890.850.36158.660.5160.1639.2241.480.8240.480.9917.00136.2216.88-3.63-0.44NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30
Revenues 0.120.030.020.270.280.710.932.862.530.950.892.785.903.340.870.261.22
A2seventy Bio Inc, License Non Affiliate NANANANA0.000.20NANA2.000.10NANANANANANANA
Chiesi Farmaceutici Sp A, License Non Affiliate 0.120.030.02NA0.260.100.24NA0.050.080.22NA1.972.930.87NA0.79
Phylaxis Bio Science L L C, License Non Affiliate NANANANA0.010.410.67NA0.460.740.64NA0.81NANANANA
A2seventy Bio Inc, License Non Affiliate, A2020 Option And License Agreement NANANANA0.000.20NANA0.000.10NANANA0.40NANANA
License Non Affiliate 0.120.030.02NA0.280.710.92NA2.510.920.86NA3.833.330.87NA0.79
Grant NANANA0.000.000.000.010.020.020.040.030.000.070.01NA-0.000.42
License 0.120.030.020.270.280.710.922.842.510.920.862.785.833.330.870.270.79

Plots across concepts


IncomeStatement
Net Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Property Plant And Equipment Net
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Contract With Customer Liability Current
Noncurrent Liabilities
Operating Lease Liability Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Noncurrent
NonoperatingIncomeExpense
Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Undiscounted Excess Amount

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:MajorCustomers, us-gaap:ProductOrService
(None, 'inhibrx:LicenseNonAffiliate')
Revenuesus-gaap: Major Customers, us-gaap: Product Or Service
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType, us-gaap:IncomeStatementLocation
('us-gaap:EmployeeStockOption', None)
Allocated Share Based Compensation Expenseus-gaap: Award Type, us-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:ContractWithCustomerLiabilityCurrent
us-gaap:MajorCustomers
(None,)
Contract With Customer Liability Currentus-gaap: Major Customers
us-gaap:LongTermDebt
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
(None, 'us-gaap:SecuredDebt')
Long Term Debtus-gaap: Debt Instrument, us-gaap: Longterm Debt Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:DepreciationDepletionAndAmortization
us-gaap:IncomeStatementLocation
(None,)
Depreciation Depletion And Amortizationus-gaap: Income Statement Location
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:MajorCustomers, us-gaap:ProductOrService
(None, 'inhibrx:LicenseNonAffiliate')
Revenuesus-gaap: Major Customers, us-gaap: Product Or Service